Saved in:
| Main Authors: | John‐Anthony Coppola, Debbie‐Ann Shirley, Emily Martin, Varvara Probst, Dipankar Gupta |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | https://onlinelibrary.wiley.com/doi/10.1111/ctr.70187 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
De Novo Letermovir for Cytomegalovirus Prophylaxis in High‐Risk Liver Transplant Recipients
by: Hanna L. Kleiboeker, et al.
Published: (2025)
by: Hanna L. Kleiboeker, et al.
Published: (2025)
Letermovir Conversion for Cytomegalovirus Prophylaxis in Solid Organ Transplant
by: Suneri J. Amin, et al.
Published: (2025)
by: Suneri J. Amin, et al.
Published: (2025)
Pulse Wave Velocity in Pediatric Heart Transplant Recipients–A Marker of Vascular Health
by: John‐Anthony Coppola, et al.
Published: (2025)
by: John‐Anthony Coppola, et al.
Published: (2025)
Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature
by: Abdallah Mughrabi, et al.
Published: (2026)
by: Abdallah Mughrabi, et al.
Published: (2026)
Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients
by: Vaisak O. Nair, et al.
Published: (2025)
by: Vaisak O. Nair, et al.
Published: (2025)
Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance
by: Margaret R. Jorgenson, et al.
Published: (2024)
by: Margaret R. Jorgenson, et al.
Published: (2024)
De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of Care
by: Hanna L. Kleiboeker, et al.
Published: (2025)
by: Hanna L. Kleiboeker, et al.
Published: (2025)
Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers
by: Lemuel R. Non, et al.
Published: (2024)
by: Lemuel R. Non, et al.
Published: (2024)
Chronic Antibiotic Prophylaxis to Prevent Recurrent Cholangitis in Liver Transplant Recipients
by: Florence Runyo, et al.
Published: (2025)
by: Florence Runyo, et al.
Published: (2025)
Twelve‐Month Clinical and Cost Outcomes of Removal of Cytomegalovirus Intravenous Immune Globulin From Heart Transplantation Protocol
by: Madhumita Rao, et al.
Published: (2025)
by: Madhumita Rao, et al.
Published: (2025)
Utility of the 6‐Min Walk Test for Assessing Physical Performance in Pediatric Heart Transplant Recipients
by: Heidi Mäenpää, et al.
Published: (2025)
by: Heidi Mäenpää, et al.
Published: (2025)
The Use of Pediatric Donors in Pancreas Transplantation
by: Arianna Cabrales, et al.
Published: (2026)
by: Arianna Cabrales, et al.
Published: (2026)
Expanding Perspectives on Sarcopenia and Frailty Risk in Heart Transplant Recipients
by: Lien‐Chung Wei, et al.
Published: (2025)
by: Lien‐Chung Wei, et al.
Published: (2025)
The Nordic Experience of Pediatric Heart‐Lung Transplantation
by: Oscar van der Have, et al.
Published: (2026)
by: Oscar van der Have, et al.
Published: (2026)
Advancement of Heart Transplantation in Thai Recipients: Survival Trends and Pharmacogenetic Insights
by: Siwaporn Manomaisantiphap, et al.
Published: (2025)
by: Siwaporn Manomaisantiphap, et al.
Published: (2025)
What I Wish I Knew: The Reality of Heart Transplant Recipients
by: Sara Mack, et al.
Published: (2026)
by: Sara Mack, et al.
Published: (2026)
Long‐Term Outcomes Among Lung Transplant Recipients With High‐Risk Cytomegalovirus Mismatch Managed With a Multimodality Regimen
by: Natasha Banga, et al.
Published: (2025)
by: Natasha Banga, et al.
Published: (2025)
Clinical Utility of Donor‐Derived Cell‐Free DNA in Heart Transplant Recipients With Multi‐Organ Transplants
by: Cathrine M. Moeller, et al.
Published: (2024)
by: Cathrine M. Moeller, et al.
Published: (2024)
Evolving Trends and Impact of Waitlist Transfusion on Recipient Outcomes Following Heart Transplantation
by: Yeahwa Hong, et al.
Published: (2024)
by: Yeahwa Hong, et al.
Published: (2024)
Changes in Medication Adherence Across the Posttransplant Period in Pediatric Organ Transplant Recipients
by: Michael O. Killian, et al.
Published: (2024)
by: Michael O. Killian, et al.
Published: (2024)
Conditions Associated With the Onset of Cancer After Heart Transplant: Longitudinal Study in 335 Recipients
by: Fabian Patauner, et al.
Published: (2025)
by: Fabian Patauner, et al.
Published: (2025)
Outcomes of Donor‐Recipient Size Mismatch in Donation After Circulatory Death Heart Transplantation
by: Iris Feng, et al.
Published: (2025)
by: Iris Feng, et al.
Published: (2025)
Neighborhood Deprivation Linked to Medication Level Variability in Liver Transplant Recipients
by: Laila Fozouni, et al.
Published: (2025)
by: Laila Fozouni, et al.
Published: (2025)
Risk Factors and Outcomes of Invasive Candida Infections in Heart Transplant Recipients: A Case‐Control Study
by: Majd Alsoubani, et al.
Published: (2025)
by: Majd Alsoubani, et al.
Published: (2025)
Outcomes and Tolerability of Early Mammalian Target of Rapamycin Inhibitor Initiation for Renal Sparing in Heart Transplant Recipients
by: Avery Marcotte, et al.
Published: (2025)
by: Avery Marcotte, et al.
Published: (2025)
Abdominal Gynecologic Procedures in Pancreas Transplant Recipients
by: Allison Drury, et al.
Published: (2024)
by: Allison Drury, et al.
Published: (2024)
Pretransplant Diabetes Mellitus and Obesity in Recipients Is Associated With Reduced Survival Following Donation After Circulatory Death Heart Transplantation
by: Yeahwa Hong, et al.
Published: (2025)
by: Yeahwa Hong, et al.
Published: (2025)
Kidney Allograft Outcomes of Dual‐Organ Heart Kidney Transplant Recipients Following Donation After Circulatory Determination of Death
by: Ananya Gorrai, et al.
Published: (2026)
by: Ananya Gorrai, et al.
Published: (2026)
Contemporary Cytomegalovirus (CMV) Infections in Low‐Risk CMV Seronegative Recipients of Solid Organ Transplants From CMV Seronegative Donors (D−/R−): Time to Reexamine Donor CMV Serostatus
by: Madeleine R. Heldman, et al.
Published: (2024)
by: Madeleine R. Heldman, et al.
Published: (2024)
Alternative Measures of Body Composition and Outcomes Following Heart Transplant
by: Ana Lanier, et al.
Published: (2026)
by: Ana Lanier, et al.
Published: (2026)
Survival Outcomes of Liver Transplantation Amid Rising Recipient and Donor Risk Profiles
by: Eishan Ashwat, et al.
Published: (2025)
by: Eishan Ashwat, et al.
Published: (2025)
Impact of Heart Failure Etiology on Waitlist Mortality in Heart Transplant Candidates Supported With Extracorporeal Membrane Oxygenation
by: Manuj M. Shah, et al.
Published: (2024)
by: Manuj M. Shah, et al.
Published: (2024)
Comparison Between Black Non‐Hispanic and White Non‐Hispanic Simultaneous Pancreas‐Kidney Transplant Candidates and Recipients
by: Shawna M. Green, et al.
Published: (2024)
by: Shawna M. Green, et al.
Published: (2024)
Epidemiology, Treatment, and Outcomes of Gram‐Negative Bacteremia in a Multicenter Cohort of Solid Organ Transplant Recipients
by: Sarah B. Doernberg, et al.
Published: (2025)
by: Sarah B. Doernberg, et al.
Published: (2025)
LCP‐Tacrolimus Extended‐Release (Envarsus XR) Use in Adolescent and Young Adult Solid Organ Transplant Recipients
by: Esther K. Bae, et al.
Published: (2024)
by: Esther K. Bae, et al.
Published: (2024)
Tailoring Liver Transplant Decisions: How Donor–Recipient Age Matching Influences Outcomes
by: Abiha Abdullah, et al.
Published: (2026)
by: Abiha Abdullah, et al.
Published: (2026)
The Presence of Non‐HLA Antibody With DSA Is Associated With Moderate to Severe T Cell‐Mediated Rejection in Liver Transplant Recipients
by: Qingyong Xu, et al.
Published: (2026)
by: Qingyong Xu, et al.
Published: (2026)
SARS‐CoV‐2 Vaccination Rates and Uptake of Tixagevimab‐Cilgavimab Among a Cohort of Pediatric Solid Organ Transplant Recipients
by: Christopher A. Reis, et al.
Published: (2024)
by: Christopher A. Reis, et al.
Published: (2024)
High Incidence of Undiagnosed Hepatocellular Carcinoma in Transplant Recipients With Metabolic‐Associated Steatotic Liver Disease
by: Emily A. Leven, et al.
Published: (2026)
by: Emily A. Leven, et al.
Published: (2026)
Impact of the Distance Between Patient Residency and Heart Transplant Center on Outcomes After Heart Transplantation
by: Waleed Ahmad, et al.
Published: (2024)
by: Waleed Ahmad, et al.
Published: (2024)
Similar Items
-
De Novo Letermovir for Cytomegalovirus Prophylaxis in High‐Risk Liver Transplant Recipients
by: Hanna L. Kleiboeker, et al.
Published: (2025) -
Letermovir Conversion for Cytomegalovirus Prophylaxis in Solid Organ Transplant
by: Suneri J. Amin, et al.
Published: (2025) -
Pulse Wave Velocity in Pediatric Heart Transplant Recipients–A Marker of Vascular Health
by: John‐Anthony Coppola, et al.
Published: (2025) -
Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature
by: Abdallah Mughrabi, et al.
Published: (2026) -
Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients
by: Vaisak O. Nair, et al.
Published: (2025)